Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA||033C21A / 2||LA / IM|
Administered by: Private Purchased by: ??
Symptoms: No adverse event, Interchange of vaccine products, COVID-19, SARS-CoV-2 test positive
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type':
Write-up: patient has reported no adverse event from her COVID vaccine. We are notifying you of an inadverdant admisnitration of the Moderna Vaccine to patient who had already received one dose fo the PFizer COVID vacccine. patient received Pfizer vaccine on 3/16/2021, developed COVID and was treated with monoclonal antibodies on 3/22/2021 . She presented for COVID vaccine and reported that she was instructed by her healthcare porvider that she could receive Moderna eben though she had started series with Pfizer. She had no reaction post vaccine and was instaructed that she had completed her mRNA vaccine series now.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166